Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period
- PMID: 33005267
- PMCID: PMC7509899
- DOI: 10.5114/pg.2020.98537
Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period
Abstract
Introduction: Rapid diagnosis is important for preventing infections due to vancomycin-resistant enterococci.
Aim: To evaluate the status of gastrointestinal colonisation with strains containing vanA/vanB genes in oncological patients.
Material and methods: A total of 167 samples of rectal swabs taken from 161 patients (mean age: 63, range: 29-93 years) were examined, including 113 patients from surgical wards (70.2%) and 48 patients from non-surgical wards (29.8%), with diagnosed cancer. The tests were carried out within 24 h of admitting the patient to the department, using the Cepheid Xpert vanA/vanB test, with a CE marked GeneXpert® Instrument Systems analyser. Samples with positive vanB gene results were additionally seeded on chromogenic media.
Results: The presence of the vanA gene was found in 2.7% and 6.3% of the examined patients, respectively, from the surgical and non-surgical departments, which accounted for 3.7% of all the patients examined. The presence of the vanB gene was detected in 21.1% of the patients, but in no case was there any growth of vancomycin-resistant enterococci on the chromogenic medium.
Conclusions: Patients admitted to non-surgical wards were more often colonised with vanA/vanB genes than were patients admitted to surgical wards, but the differences were not statistically significant.
Keywords: colonisation; oncological patients; vanA/vanB enterococci.
Copyright © 2020 Termedia.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Matar MJ, Tarrand J, Raad I, et al. . Colonization and infection with vancomycin-resistant enterococcus among patients with cancer. Am J Infect Control 2006; 34: 534-6. - PubMed
-
- Surveillance of antimicrobial resistance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-r... (November 2018).
-
- Zalecenia prowadzenia mikrobiologicznych badań przesiewowych u hospitalizowanych pacjentów, Narodowy Program Ochrony Antybiotyków na lata 2016-2020, NIL, Warszawa 2017, https://antybiotyki.edu.pl/wp-content/uploads/Rekomendacje/drZALECENIAPR....
-
- Ariza-Heredia EJ, Chemaly RF. Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges. CI Lymph Myelom Leuk 2014; 14 (Suppl): 104-10. - PubMed
LinkOut - more resources
Full Text Sources